+ |
lapatinib | down-regulates
chemical inhibition
|
ERBB2 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-177081 |
|
|
Homo sapiens |
Breast Cancer Cell |
pmid |
sentence |
22056878 |
In estrogen-receptor-negative cellular models showing coamplification of erbb2 and rara, simultaneous targeting of the corresponding gene products with combinations of lapatinib and atra causes synergistic growth inhibition, cyto-differentiation and apoptosis. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-193627 |
|
|
Homo sapiens |
|
pmid |
sentence |
Other |
|
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
lapatinib | down-regulates activity
chemical inhibition
|
EGFR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-258234 |
|
|
in vitro |
|
pmid |
sentence |
22037378 |
Our data set represents the most detailed comprehensive assessment of the reactivity of known and clinical kinase inhibitors across the kinome published to date. | The data also show that for at least 15 of the 27 kinases that are the primary, intended targets for the compounds tested and that are represented in the assay panel, selective inhibitors, as assessed by both absolute selectivity across the kinome and selectivity relative to the primary target, are among the 72 tested here. |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
lapatinib | down-regulates activity
chemical inhibition
|
RET |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-257899 |
|
|
Homo sapiens |
HUVEC Cell |
pmid |
sentence |
21443688 |
YN968D1 potently suppressed the kinase activities of VEGFR-2, c-kit and c-src, and inhibited cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
lapatinib | down-regulates activity
chemical inhibition
|
KIT |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-257901 |
|
|
Homo sapiens |
HUVEC Cell |
pmid |
sentence |
21443688 |
YN968D1 potently suppressed the kinase activities of VEGFR-2, c-kit and c-src, and inhibited cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
lapatinib | down-regulates
chemical inhibition
|
EGFR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-157867 |
|
|
Homo sapiens |
Breast Cancer Cell |
pmid |
sentence |
17892419 |
Recently, lapatinib, a small molecule dual inhibitor of both her2 and egf receptors, has been developed to expand the options for treating her-positive breast cancer. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
lapatinib | down-regulates activity
chemical inhibition
|
CSK |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-257900 |
|
|
Homo sapiens |
HUVEC Cell |
pmid |
sentence |
21443688 |
YN968D1 potently suppressed the kinase activities of VEGFR-2, c-kit and c-src, and inhibited cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
lapatinib | down-regulates activity
chemical inhibition
|
ERBB2 |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-258131 |
|
|
in vitro |
|
pmid |
sentence |
22037378 |
Our data set represents the most detailed comprehensive assessment of the reactivity of known and clinical kinase inhibitors across the kinome published to date. | The data also show that for at least 15 of the 27 kinases that are the primary, intended targets for the compounds tested and that are represented in the assay panel, selective inhibitors, as assessed by both absolute selectivity across the kinome and selectivity relative to the primary target, are among the 72 tested here. |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
lapatinib | down-regulates activity
chemical inhibition
|
KDR |
0.8 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-257898 |
|
|
Homo sapiens |
HUVEC Cell |
pmid |
sentence |
21443688 |
YN968D1 potently suppressed the kinase activities of VEGFR-2, c-kit and c-src, and inhibited cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |